Endoscopic variceal ligation is cost-effective relative to beta-blockers for the prevention of variceal bleeding in cirrhotic patients if quality of life-years are considered. If only life-years are considered, then endoscopic variceal ligation is not cost-effective.
Donald Metcalf, M.D., the physiologist renowned as “the father of hematopoietic cytokines” for his pioneering work on the control of blood cell formation, will receive the American Association for Cancer Research Award for Lifetime Achievement in Cancer Research.
Actigraphy, the use of a portable device that records movement over extended periods of time, and has been used extensively in the study of sleep and circadian rhythms, provides an acceptably accurate estimate of sleep patterns in normal, healthy adult populations and in-patients suspected of certain sleep disorders, according to practice parameters published in the April 1st issue of the journal SLEEP.
The U.S. Food & Drug Administration (FDA) is launching a special Web page to warn consumers about the dangers of buying isotretinoin (Accutane) online.
Dr Gill Morgan, chief executive of the NHS Confederation which represents over 90 per cent of NHS organisations, said:
Reported outbreaks of Rift Valley Fever (RVF) among animals began on 18_January 2007 with the first human case reported at the beginning of February 2007 in Arusha region.
A new study estimated the prevalence of Arthritis-attributable work limitation (AAWL) in adults between the ages of 18 and 64 and examined characteristics related to AAWL in this age group.
Two Rutgers College of Nursing faculty members are conducting a study to develop and test a targeted intervention to reduce symptoms and improve the quality of life of patients undergoing prostate cancer treatment.
Older women with breast cancer get a lower level of care than younger women, researchers at the University of Manchester have found.
The Institute for OneWorld Health, a US-based non-profit pharmaceutical company that develops drugs for people with neglected diseases in the developing world, today announced the selection of Odyssey Research, a Bismarck, North Dakota-based clinical trial management organization (TMO) with offices in New Delhi, India, to support its upcoming Phase 4 pharmacovigilance and access study of Paromomycin Intramuscular (IM) Injection for the treatment of visceral leishmaniasis (VL) in India.